FDA
The union for managers and professionals in public service
Home  >  Topic Search Results

Topic Search Results

Showing articles tagged with: Pay
 
Genderpaygap555

The FDA responds to newly published civil service gender pay gap departmental reports for 2023

01 December 2023
News
Arrows-555

The FDA’s new report, ‘The state of pay in the civil service’, paints a stark picture, with unambiguous testimony from civil servants detailing widespread dissatisfaction with the pay system, which is having a devasting impact on morale.

23 November 2023
News
FastStreamCommittee2023-555

Scott Dobson reports on the FDA's historic win on Fast Stream pay.

20 November 2023 | By Scott Dobson
Feature
CabinetOffice555

Members in the FDA’s Fast Stream Section vote to accept a pay offer worth up to 22.5%.

30 August 2023
News
Downing-Street-Whitehall-555

The FDA has written jointly with Prospect to the Minister for the Cabinet Office Jeremy Quin to push for reform of the civil service pay system.

02 August 2023
News
PSM_Summer 23_pay_555

Following the publication in April of the government’s Pay Remit Guidance for 2023/24, the FDA announced plans for a ballot on national industrial action on pay for the first time in 40 years.

24 July 2023
Feature
SSRB 45th Annual Report on Senior Salaries 2023 555

The FDA has today welcomed the recommendations made by the Senior Salaries Review Body, and the government’s decision to accept those recommendations in full.

13 July 2023
News
DaveADC2023-podium-555

Following the FDA’s success in the getting the government improve the 2023/24 pay offer, the union now looks ahead to bring around strategic change.

13 June 2023
News
Enough-is-enough555

The Minister for the Cabinet Office has today presented a new package intended to recognise the contribution made by civil servants and the pressures felt during 2022/23.

02 June 2023
News
value logo - 555

The FDA’s Executive Committee has today agreed to suspend the union’s ballot on industrial action over pay, which was due to start on Tuesday 30 May, following a formal invitation from government to enter talks.

26 May 2023
News
FDA Picket 555

General Secretary sets out why the FDA is launching a national strike ballot

25 April 2023 | By Dave Penman
Analysis/comment
Dave-Penman-Conference-2022-7625-555

General Secretary Dave Penman reacts to the government publishing the Civil Service Pay Remit Guidance, with a headline figure of a 4.5% increase with no non-consolidated award

14 April 2023
Analysis/comment
Civil Service Pay Remit Guidance 2023 to 2024 555

The FDA’s Executive Committee will meet on Wednesday 19 April 2023 to consider a national ballot for industrial action in the civil service.

14 April 2023
News
IDR555

The FDA has submitted an independent analysis of the government’s published economic evidence to the Pay Review Bodies

24 February 2023
News
Victoria-Taylor-WiL-18-thumbnail-555

FDA Fast Stream reps Simon and Natasha on the campaign for better pay, and why there has never has been a better time to join the FDA.

29 September 2022
Feature
Liz-Truss2-555

The FDA rebuffed Truss’s recycled policies and help force her U-turn

03 August 2022
News

FDA General Secretary Dave Penman on the stark message for civil servants from this year’s pay remit guidance.

03 May 2022 | By Dave Penman
Analysis/comment
Cabinet office

Following the publication of the 2022/23 Pay Remit Guidance, FDA General Secretary Dave Penman accuses the government of abandoning its own workforce and ignoring the cost of living crisis.

01 April 2022 | By Dave Penman
Analysis/comment

The FDA has published its evidence to the National Crime Agency's Pay Review Body.

01 March 2022
News
Steven-Littlewood-Wales-555

National Officer Steven Littlewood reflects on the historic Fast Stream pay settlement and how none of it would have been possible without the “show of determination” from Fast Stream members.

16 September 2021 | By Steven Littlewood
Analysis/comment
12345
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA